Moneycontrol PRO
HomeNewsBusinessCOVID-19 a defining moment; these are the times to question everything, says Harsh Mariwala

COVID-19 a defining moment; these are the times to question everything, says Harsh Mariwala

The Marico chairman talks on lessons and life during COVID-19, and shares how he makes the most of work from home.

April 08, 2020 / 14:18 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Harsh Mariwala has been an entrepreneur for nearly 50 years, and has seen through many a boom and downturn to create a billion-dollar enterprise in Marico. But even the seasoned entrepreneur has been taken aback by the disruption created by COVID-19.

    "I have never seen anything like this in my career," says Mariwala in an interaction with Moneycontrol. 

    At the same time, the Marico chairman believes, this could be a defining moment. "These are the times when you virtually start questioning everything. There are lessons for all human beings, the attention we give to health or environment, and issues like sustainability and even supply chain issues," said Mariwala.

    India has now reported 5,000 people with the COVID-19 infection, and 149 have died. Globally, the virus has taken the lives of more than 82,000 people, and nearly 15 lakh people have been reportedly infected.

    The virus, and the resultant lockdown, has created a huge dent on economic activity with many sectors, including aviation and auto, facing severe crisis.

    COVID-19 Vaccine

    Frequently Asked Questions

    View more
    How does a vaccine work?

    A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

    How many types of vaccines are there?

    There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

    What does it take to develop a vaccine of this kind?

    Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

    View more
    Show

    But there are lessons to be learnt, for Indian entrepreneurs and CEOs on conducting business.

    For instance, says Mariwala, entrepreneurs may now avoid calling over people for meetings in office, and instead do with a video call. "Sometimes people have to travel two hours to do a 15-minute meeting. From now on, unnecessary travel, including inter-city, will be avoided," says Mariwala.

    Work from home

    How about work-from-home, something that has come into focus during these times? While Mariwala agrees that for specialised, individualistic jobs, work-from-home may work, working in office has its benefits.

    "One gets to think and have dialogues at office," says Mariwala, clearly indicating his preference.

    That, however, hasn't prevented the veteran businessman and a doting grandfather to make the most of the time he is spending at home. "Now I'm able to spend more time with my grandchildren," he says.

    Mariwala has created a schedule that includes yoga routines in the morning, checking mails, doing call and an evening walk. "Every evening, I and my wife catch up with our friends on Zoom app. There are about 10 of us, and we chat. Sometimes we even pour a drink for ourselves," he adds, with a chuckle.

    Lessons for the FMCG sector

    COVID-19 has seen customers lining up at outlets to stock up on essentials. Demand for some of the products has shot up.

    This means that the FMCG sector may not be as impacted as the other sectors. "It is less impacted, as consumer spending on these goods has not been impacted as much as, say on cars," says Mariwala.

    At the same time, the lockdown and the increased demand have led to disruptions in supply chain. "We are facing a lot of issues because of lack of transportation and people. Right now, only 25 percent of the demand is being met," says Mariwala.

    The experience though could now make companies look at supply chains differently. "Earlier there was a trend of zero inventory. After the present experience, people will start questioning that practice," says the entrepreneur.

    "If one is highly dependent on one country, say China, for a raw material, then there will be a need to broaden the base. There will be supply chain-rethinking," points out Mariwala.

    There could be other opportunities too. COVID-19 has brought back the focus on hygiene and health, and this, he says, will lead to FMCG companies coming out with more products that centre around health, hygiene and sustainability.

    Countering the virus

    India Inc has responded to the COVID-19 pandemic in a resounding way, with entrepreneurs and companies announcing aids, or converting their facilities to produce equipment that can be used to fight the virus.

    Mariwala has called on entrepreneurs to come up with innovative ideas to fight the virus, promising them with grant and help, to come out with products.

    He has teamed up with Amit Chandra, Chairman of Bain Capital Private Equity, to launch the #Innovate2BeatCOVID challenge. Handled by their foundations - Marico Innovation Foundation and A.T.E. Chandra Foundation - the challenge has got over 1,000 interests.

    "Based on the demand for things like masks, ventilators and other equipment needed to fight the virus, we realised that there could be a shortage," says Mariwala.

    The challenge, he adds, is an opportunity for innovators to come up with quick ideas that can be translated into products. The challenge, the last date for which is April 10, comes with a grant of Rs 2.5 crore. There is scope, says Mariwala, to increase the grant to Rs 5 crore.

    After the initial filtering, a jury - which includes scientist Dr RA Mashelkar, will select the winners. "We will act as a catalyst. Apart from the award, we will hand-hold the company or an individual in areas where there is a need. Someone may need regulatory help, others space for manufacturing," adds the entrepreneur.

    Prince Mathews Thomas
    Prince Mathews Thomas heads the corporate bureau of Moneycontrol. He has been covering the business world for 16 years, having worked in The Hindu Business Line, Forbes India, Dow Jones Newswires, The Economic Times, Business Standard and The Week. A Chevening scholar, Prince has also authored The Consolidators, a book on second generation entrepreneurs.
    first published: Apr 8, 2020 02:18 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347